According to UnivDatos analysis, rising prevalence of liver cancer, uterine fibroids, and vascular disorders, technological advancements in embolic agents, and growing FDA approvals are the major factors driving the growth of the embolotherapy market. As per their “Embolotherapy Market” report, the global market was valued at USD 4,084.29 million in 2024, growing at a CAGR of about...